☰
×
News
Top 20
Insights
Insights+
ThoughtSpot
Interviews
Viewpoints
Exclusive
Spotlight
Events
Magazine
Bespoke
Newswire
x
Search
Search here
Search here
Subscribe Now
Co-commercialization
Eisai Collaborates with BMS for the Co-Development and Co-Commercialization of MORAb-202
June 21, 2021
RedHill Replaces its Co-Commercialization Agreement with Daiichi Sankyo for Movantik (naloxegol)
August 4, 2020
Load more...
Back to Home
